#Rna Transcriptomics Market: Leading Players Developments | Explore Tumblr posts and blogs

bisresearch0 · 9 days ago

Text

Spatiotemporal Omics Market: Growth Trends, Technologies, and Future Forecast

What is spatiotemporal omics?

Spatiotemporal omics is an advanced approach in molecular biology that integrates spatial and temporal dimensions into multi-omics analyses (e.g., genomics, transcriptomics, proteomics, metabolomics). This technique enables the mapping of biomolecular changes within the precise anatomical context of tissues over time, offering unprecedented resolution into how cellular behavior evolves in health and disease. It has transformative potential in areas such as oncology, neuroscience, immunology, and developmental biology, driving innovation in precision medicine and systems biology.

The Spatio OMICS Market is expected to grow at a significant rate due to advancements in sequencing and imaging technologies, and expansion of research and development funding.

Which technologies are driving the spatiotemporal omics market?

Spatial Transcriptomics – Maps gene expression in tissue context

Spatial Proteomics – Visualizes protein distribution

Mass Spectrometry Imaging (MSI) – Detects molecules with spatial precision

Single-Cell RNA Sequencing (scRNA-seq) – Captures temporal changes at cell level

Multiplexed Imaging (e.g., CODEX, MIBI) – Analyzes many biomarkers in tissues

What are the current limitations or challenges in spatiotemporal omics adoption?

High Technology Costs: The advanced instruments and reagents required for spatiotemporal omics are costly, making adoption challenging for many academic and smaller research institutions. This financial barrier limits access despite rising interest in spatial biology.

Complexity of Data Analysis: Spatiotemporal omics generate vast, high-dimensional datasets combining molecular and imaging data. Processing this information demands specialized software, computational infrastructure, and bioinformatics expertise. Without these, deriving actionable insights can be slow and resource-intensive.

Limited Skilled Workforce and Infrastructure: The field requires interdisciplinary skills in molecular biology, spatial imaging, and data science. However, a shortage of trained professionals and inadequate infrastructure in many regions slows down adoption and implementation across research and clinical environments.

To get detailed information on Spatiotemporal OMICS Industry, Click here!

Which regions are investing heavily in spatiotemporal omics research and development?

North America

Europe

Asia-Pacific

Latin America

Who are the leading players in the spatiotemporal omics industry?

10x Genomics

NanoString Technologies

Akoya Biosciences

Bruker Corporation

Vizgen

RareCyte

For a comprehensive analysis, refer to the full report by BIS Research: Spatiotemporal OMICS Market.

End Use Insights

Innovation Strategy: It identifies opportunities for market entry and technology adoption, helping organizations stay ahead of the competition while meeting evolving customer demands.

Growth Strategy: The report outlines targeted growth strategies to optimize market share, enhance brand presence, and drive revenue expansion.

Competitive Strategy: It evaluates key competitors and offers practical guidance for maintaining a competitive edge in a rapidly evolving market.

Conclusion

The market for spatiotemporal omics is expected to increase significantly due to growing applications in clinical and research settings, growing need for precision medicine, and technical advancements. To keep a competitive edge, major competitors in the market are always improving their product offerings, investing in R&D, and inventing. Despite obstacles like exorbitant expenses and intricate data, the amalgamation of artificial intelligence and multi-modal platforms offers significant prospects. Organizations that use these insights can take advantage of development opportunities, overcome obstacles, and set themselves up for long-term success in the ever-changing spatiotemporal omics landscape.

#Spatiotemporal Omics Market #Spatiotemporal Omics Industry #Spatiotemporal Omics Report #health #healthcare

0 notes

healthlogic · 1 year ago

Text

RNA Analysis/Transcriptomics Market Partnering Deals of Key Players 2024 – 2031

The Insight Partners market research RNA Analysis/Transcriptomics Market Size and Share Report | 2031 is now available for purchase. This report offers an exclusive evaluation of a range of business environment factors impacting market participants. The market information included in this report is assimilated and reliant on a few strategies, for example, PESTLE, Porter's Five, SWOT examination, and market dynamics

RNA Analysis/Transcriptomics market is evaluated based on current scenarios and future projections are added keeping the projected period in consideration. This report integrates the valuation of RNA Analysis/Transcriptomics market size for esteem (million USD) and volume (K Units). Research analysts have used top-down, bottom-up, primary, and secondary research approaches to evaluate and approve the RNA Analysis/Transcriptomics market estimation.

Detailed scrutiny of market shares, optional sources, and basic essential sources has been done to integrate only valid facts. This research further reveals strategies to help companies grow in the RNA Analysis/Transcriptomics market.

Key objectives of this research are:

To contemporary market dynamics including drivers, challenges, threats, and opportunities in the RNA Analysis/Transcriptomics market.

To analyze the sum and market estimation of the worldwide RNA Analysis/Transcriptomics market

Based on key facets, market segments are added.

The competitive analysis covers key market players and their business strategies.

To examine the RNA Analysis/Transcriptomics Market for business probable and strategic outlook.

To review the RNA Analysis/Transcriptomics Market size, key regions and countries, end-users, and statistical details.

To offer strategic recommendations based on the latest market developments, and RNA Analysis/Transcriptomics market trends.

Perks of The Insight Partners’ RNA Analysis/Transcriptomics Market Research

Market Trends: Our report reveals developing RNA Analysis/Transcriptomics market trends that are poised to reshape the market preparing businesses with the foresight to retain their competitive edge. This Market research report presents market trends, supply chain analysis, leading participants, and business growth strategies. This research covers technological progress and key developments covering various aspects of the inclusive market. It is valuable market research for existing key players as well as new entrants in the RNA Analysis/Transcriptomics Market. Through inputs derived from experts, this research attempts to guide future investors about market details and potential returns on investment.

Competitive Landscape: This research reveals key market players, their strategies, and possible areas for differentiation.

Analysts Viewpoint: We have industry-specific experts who add credibility to this report with their exclusive viewpoints based on market understanding and expertise. This report goes further into details of entire business processes and doesn’t restrict to only operational aspects. These insights cover venture economics and include tactics for capital investment, investor funding, and projections of ROIs. Net income and profit loss financial stats are crucial metrics of this RNA Analysis/Transcriptomics market report. With these meticulous insights companies can reduce their risks and increase the success rate in the coming decade.

RNA Analysis/Transcriptomics Market Report Coverage:

Report Attributes

Details

Segmental Coverage

Product

Consumables

Instruments

Software Services

Technology

Microarray

Real-Time Quantitative Polymerase Chain Reaction

Sequencing Technologies

Application

Diagnostics Disease Profiling

Drug Discovery Others

End User

North America

Europe

Asia Pacific

South Central America

and Geography

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

BioRad Laboratories Inc.

Illumina Inc.

GE Healthcare

F. HoffmannLa Roche Ltd.

Agilent Technologies Inc.

Thermofisher Scientific Inc.

Sigma Aldrich

Qiagen N.V.

Affymetrix Inc.

Fluidigm Corporation

Other key companies

What all adds up to the credibility of this research?

A comprehensive summary of the contemporary RNA Analysis/Transcriptomics market scenario

Precise estimations on market revenue forecasts and CAGR to rationalize resources

Regional coverage to uncover new markets for business

Rivalry analysis aims to help corporations at a modest edge

Facts-based crystal-clear insights for business success

The research can be customized as per business necessities

Access to PDF, and PPT formats of this research

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Chemicals and Materials.

#RNA Analysis/Transcriptomics Market

1 note · View note

the-rachana · 3 years ago

Text

Massive Growth of Transcriptomics Market by 2029 with Top Key Players: Illumina Inc., Eurofins Scientific SE, Merck KgaA, Acobiom

The global transcriptomics market peaked at US$ 4.5 billion in 2021. The market is expected to witness a CAGR of 13.50% from 2022 to 2030.

RNA sequencing truly has revolutionized transcriptome examination, permitting the quantification of gene expression levels and allele-specific expression in single research, as well as the affinity of new genes, splice isoforms, fusion transcripts, and extraordinary research into the world of non-coding RNA. The demand for RNA sequencing in the research field is growing because it uses a highly scientific study to obtain information at the genetic level, although it is highly sensitive to genes that produce output very smoothly when using this technology.

Transcriptomics is the study of the transcriptome which is the entire set of RNA transcripts created by the genome under certain circumstances or in a specific cell, using highly specific scientific methods. The market is influenced by factors such as increased research on new chronic diseases, the rise in the application of RNA sequencing, and funding provided by the government in omics. For instance, the Life Sciences Innovative Manufacturing Funds (LSIMF) Which is a part of global Britain Investments Funds, invested 354 million euros, in March 2022.

Get a Sample PDF of the Report - https://growthplusreports.com/inquiry/request-sample/transcriptomics-market/7733

Key Players Mentioned in the Transcriptomics Market:

· Bio-Rad Laboratories Inc.

· Thermo Fisher Scientific Inc.

· Agilent Technologies Inc.

· Illumina Inc.

· Qiagen N.V

· F. Hoffman La Roche Ltd.

· Eurofins Scientific SE

· Fluidigm Corporation

· Merck KgaA

· Acobiom

· CD Genomics

By Application:

· Drug Discovery

· Clinical Diagnostics

· Toxicogenomics

By Technology:

· Microarray

· Polymerase Chain Reaction

· Sequencing

Key Reasons to Purchase:

(1) To gain insightful analyses of the market and have a comprehensive understanding of the global market and its commercial landscape.

(2) Assess the production processes, major issues, and solutions to mitigate the development risk.

(3) To understand the most affecting driving and restraining forces in the Transcriptomics Market and its impact in the global market.

(4) Learn about the market strategies that are being adopted by leading respective organizations.

(5) To understand the outlook and prospects for the market.

TOC of Global Transcriptomics Market

1 Scope of the Report

1.1 Market Ecosystem

1.2 Geographic Scope

1.3 Timeline Under Consideration

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Transcriptomics Market Executive Summary

2.1 World Market Overview

2.1.1 Global Market Size 2021-2031

2.1.2 Market Size CAGR by Region 2020 VS 2028

2.2 Transcriptomics Market Segment by Type

2.2.1 Type 1

2.2.2 Type 2

Browse the full report now: https://growthplusreports.com/report/transcriptomics-market/7733

About

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

0 notes

technicalnextstuff · 3 years ago

Text

RNA Analysis And Transcriptomics Market Growth Insights 2022, Size Estimation, Emerging Trends, Business Expansion Plans, Top Leading Players, SWOT Analysis, Geographic Scope and Forecast By 2027

The RNA Analysis And Transcriptomics Market research report 2022-2027 provides a comprehensive overview of market size, share, and potential opportunities, as well as industry segmentation by product type, application, and geography. The study emphasizes product development as well as technology advancements that can help the market grow. The RNA Analysis And Transcriptomics market research…

View On WordPress

0 notes

rootsanalysis · 3 years ago

Text

Next Generation Sequencing (NGS) Kits Market, 2021-2035” report features an extensive study of the current market landscape and future potential of NGS library preparation kits over the next decade.

To order this detailed 200+ page report, please visit https://www.rootsanalysis.com/reports/next-generation-sequencing-kits-market.html

Key Inclusions

§ A detailed assessment of the current market landscape of NGS library preparation kits, featuring information on the type of nucleotide sequenced (DNA and RNA), kit components (control total RNA / DNA, adapters, primers, enzyme mixes, buffers, RNA / DNA probes and others), quantity of sample required (less than 5 ng, 5 ng to 10 ng and more than 10 ng), turnaround time (less than 5 hours, 5 hours to 10 hours and more than 10 hours), storage temperature (deep freeze, cold and room temperature), type of sample used (purified RNA / DNA, plasma, serum, urine, cells, blood, saliva and others), kit shelf life (0.5 year and 1 year), type of sequencing (whole genome sequencing, targeted sequencing, transcriptome sequencing, RNA sequencing, ChIP sequencing, exome sequencing, bisulphite sequencing, methyl sequencing, amplicon sequencing, de novo sequencing, resequencing and shotgun sequencing) and type of sequencing platform used (Illumina, BGI, Ion Torrent, Fluidigm and Oxford Nanopore Technologies). In addition, the chapter features analysis related to NGS library preparation kit providers based on parameters, such as year of establishment, company size, location of headquarters and leading players (in terms of number of products).

§ A competitiveness analysis of NGS library preparation kits based on various relevant parameters, namely supplier power (based on the experience of the developer) and product competitiveness (based on parameters, including type of nucleotide sequenced, kit components, quantity of sample required, turnaround time, type of sample used, kit shelf life, type of sequencing and type of sequencing platform used).

§ Elaborate profiles of prominent players offering NGS library preparation kits, based in North America, Europe and Asia Pacific. Each profile features a brief overview of the company, details related to its financials (if available), product portfolio, recent developments and an informed future outlook.

§ An in-depth analysis of the various patents that have been filed / granted related to NGS library preparation kits and reagents, from January 2020 to October 2021, taking into consideration parameters, such as publication year, geographical region, CPC symbols, patent focus areas, type of applicant and leading players (in terms of size of intellectual property portfolio). It also includes a patent benchmarking analysis and a detailed valuation analysis.

§ A case study on the history and evolution of genome sequencing with details on first, second and third generation sequencing platforms. The chapter includes information on the NGS technologies that are available till date. Further, it presents information on the various NGS service providers (industry and non-industry players) that are engaged in providing whole genome, whole exome and targeted sequencing services.

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

§ Type of Nucleotide Sequenced

DNA

RNA

§ Type of End User

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Hospitals and Clinics

Others

§ Key Geographical Regions

North America

Europe

Asia Pacific

Latin America

Middle East and North Africa

Rest of the World

To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/next-generation-sequencing-kits-market.html

Key Questions Answered

§ Who are the key players engaged in offering NGS library preparation kits?

§ What is the relative competitiveness of different NGS library preparation kits?

§ How is the intellectual property landscape for next generation sequencing kits likely to evolve in the foreseen future?

§ What are the factors that are likely to influence the evolution of this market?

§ How is the current and future market opportunity likely to be distributed across key segments?

You may also be interested in the following titles:

1. At-Home Blood Collection and Micro Sampling Devices Market: Industry Trends and Global Forecasts, 2021-2030

2. Global Pharmaceutical Vials Market: Industry Trends and Global Forecasts, 2021-2030

3. Novel Drug Reconstitution Systems Market: Industry Trends and Global Forecasts, 2021-2030

4. Bioprocess Controllers and Automation Systems Market: Industry Trends and Global Forecasts, 2021-2030

5. Novel Ocular Drug Delivery Devices Market: Industry Trends and Global Forecasts, 2021-2030

Cell Therapy Packaging Products and Services Market: Industry Trends and Global Forecasts, 2021-2030

Contact:

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

[email protected]

#RootsAnalysis Research Pharma Biotech Analysis Report Market

0 notes

siddheshrankamaximize · 4 years ago

Text

Transcriptomics Market Analysis By Product, Portability, Application, Region, Country: Trends, Opportunities and Forecast (2021- 2027)

Transcriptomics Market Overview:

In the biotechnology business, there is an increase in the number of PCR applications; this aspect is projected to fuel market growth. The transcriptomics market is predicted to develop due to improvements in the field of transcriptomics, such as the widespread usage of RNA-sequencing and the rise in applications of transcriptomics, such as drug discovery.

Maximize Market Research has published a comprehensive research and analysis of the Transcriptomics Market, which identifies new developments in the Transcriptomics Market and gives business insights to organisations. This research assists manufacturers, suppliers, and investors, as well as CEOs, in identifying opportunities and business optimization techniques for increasing their value in the worldwide Transcriptomics Market. Provides critical information for well-known organisations that are among the best performers. The research covers present and new markets in depth, as well as an assessment of competitiveness in shifting market circumstances.

List of Key players: Following are the number of key players studied to understand the Transcriptomics Market:

• Becton • GE Healthcare • Roche Diagnostics • Agilent Technologies • Thermo Fisher Scientific • Illumina, Inc. • F. Hoffmann-La Roche Ltd • Beckman Coulter, Inc • BD • Biological Industries • bioMérieux SA • Bio-Rad Laboratories, Inc • Cepheid • Takara Bio Inc. • Cytognomix • Edico Genome • Siemens AG • QIAGEN • Merck KGaA • Kapa Biosystems • Spatial Transcriptomics

Enquiry before buying this premium Report:

https://www.maximizemarketresearch.com/request-sample/108481

This study estimates the size of the Transcriptomics Market in terms of both value and volume. It includes a thorough examination of the market's major drivers, restraints, and opportunities. Through the Porter's five forces analysis, the study examines the major elements that contribute to the growth of the Transcriptomics Market. Furthermore, the market participants have been profiled, with a particular emphasis on their product offers.

The research also includes data in the form of statistics, facts, and figures, as well as contact information and sales contact information for the global market's leading players. There is a full picture of the global Transcriptomics Market 's competitive landscape, with all information gathered and deepened with the SWOT analysis. Opportunities for possible industrial expansion have been identified, as have the competitive threats associated.

The report also discusses critical industry niches such as items or services supplied, downstream fields, end-user customers, historical data figures for revenue and sales, market background, and more. To acquire a better understanding of the companies, global Transcriptomics Market-leading main players have been profiled. It offers specific expansions to a variety of high-level industries operating around the globe. The section also includes useful information such as an overview of the firm and its market share, company biographies, and some significant methods used by key companies to build their businesses.

The introduction of new goods and the research involved in the development of innovative products is one of the primary components that is likely to have an impact on the Transcriptomics Market. The study provides information on the sales and market growth of various markets on a regional and national scale. This report is to provide a market analysis in terms of growth patterns, prospects, and market players' contributions to market development. The research also examines market demand growth estimates for products and services.

OBJECTIVES OF THE STUDY

To analyse and forecast the market size of the global Transcriptomics Market, in terms of value and volume

To identify significant trends and factors driving or inhibiting the market growth

To analyse the opportunities in the market for stakeholders by identifying the high-growth segments

To define, describe, and forecast the market by type, application, and region

To forecast the size (in terms of value and volume) of the market and submarkets by five regions, namely, Asia-Pacific, Europe, North America, the Middle East & Africa, and South America

To strategically analyse each submarket with respect to individual growth trend and their contribution to the market

To analyse competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyse their growth strategies

Our Research Methodology:

This research study involves the use of extensive secondary sources such as encyclopedia, directories, and databases to identify and collect information useful for this technical, market-oriented, and commercial study of the Transcriptomics Market. Primary sources that include selected experts from related industries and selected suppliers have been interviewed to obtain and verify important information as well as to assess future prospects. As a part of the secondary research process, various sources have been referred to for identifying and collecting information for this study. Secondary sources include annual reports, press releases, and investor presentations of companies; white papers; certified publications, articles from recognized authors; and gold & silver standard websites.

Browse Complete Transcriptomics Market details and List Of Figures Here:

https://www.maximizemarketresearch.com/market-report/global-transcriptomics-market/108481/

About Us.:

Maximize Market Research has served esteemed clients including Yamaha, Boeing, Sensata, Etnyre, Canada, ALCOR M&A, Microsoft, Harman, and other 200 MNCs worldwide. The Company provides B2B and B2C market research on 5000 high growth emerging technologies & opportunities in Transportation, Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.We, at Maximize Market Research, are a strong unified team of industry specialists and analysts across sectors to ensure entire Industry ecosystem is taken in perspective, factoring all recent development, latest trends and futuristic – the technological impact of uniquely specific industries.

Contact Details: Maximize Market Research Pvt. Ltd. Phone: US: +1 774 775 2163; APAC: +91-9607365656 Email: [email protected] Website: www.maximizemarketresearch.com

0 notes

itssashasharma · 4 years ago

Text

Bioinformatics Services Market : Technological advancements in the field of Sequencing and Data Analysis

According to the new market research report “Bioinformatics Services Market by Type (Sequencing, Data Analysis, Discovery, Gene Expression, Database Management), Specialty (Medical, Plant, Forensics), Application (Genomics, Metabolomics), Enduser (Academia, Pharma-biotech) – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 5.3 Billion by 2026 from USD 2.5 Billion in 2021, at a CAGR of 15.8% during the forecast period.

Browse in-depth TOC on “Bioinformatics Services Market” 203 – Tables 41 – Figures 238 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75889439

Bioinformatics services have always had huge potential when it comes to providing essential support to many areas of scientific research. The COVID-19 pandemic was a real-life test for bioinformatics. One of the major focus areas for every country during the COVID-19 pandemic has been to study and understand how to halt the progress of the virus. Decoding the genome of the novel coronavirus was a crucial step in developing vaccines and for better understanding the mechanism of the virus and how it functions in the human body. Thus, various studies were undertaken to understand the genetic combination of the virus; these studies were driven by bioinformatics.

The growing applications of bioinformatics across industries, increasing public-private sector funding for bioinformatics services, and the shortage of skilled bioinformatics professionals (leading to increased outsourcing of bioinformatics projects) are the major factors that are expected to drive the growth of the market during the forecast period. However, the in-house development of bioinformatics solutions and publicly available bioinformatics tools are expected to limit market are expected to restrain market growth in the coming years.

Based on application, the bioinformatics services market is segmented into genomics, chemoinformatics and drug design, proteomics, transcriptomics, metabolomics and other applications. Large share is attributed to genomics segment due to increasing use of pharmacogenomic research for the development of precision medicine, favorable funding scenario for genomic research, and partnerships and collaborations between various life sciences and informatics companies for the development of advanced bioinformatics solutions and services.

Based on specialty, the bioinformatics services market is segmented into medical biotechnology, plant biotechnology, animal biotechnology, environment biotechnology and forensic biotechnology. Medical biotechnology holds the largest share due to the development of new databases for drug discovery, the use of bioinformatics for clinical diagnostics, and increasing funding for the development of bioinformatics solutions for clinical diagnostics.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=75889439

North America dominated the global bioinformatics services market in 2020

The North American market dominated the market. The growth in North America can be attributed to government initiatives for the reimbursement of genomic testing and favorable funding scenario for research activities.

Prominent players in the bioinformatics services market include Illumina (US), Thermo Fisher Scientific (US), Eurofins Scientific (Luxembourg), BGI Group (China), NeoGenomics (US), PerkinElmer (US), CD Genomics (US), Psomagen, Inc. (South Korea), QIAGEN (Germany), GENEWIZ (US), Source BioScience (UK), Microsynth (Switzerland), MedGenome (India), Fios Genomics (UK), and BaseClear (Netherlands), among others.

Browse Adjacent Markets: Healthcare IT Market Research Reports & Consulting

Browse Related Reports:

Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) – Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html

NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region – Global Forecast to 2024 https://www.marketsandmarkets.com/Market-Reports/ngs-based-rna-seq-market-102977816.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: [email protected] Research Insight: https://www.marketsandmarkets.com/ResearchInsight/bioinformatic-service-market.asp Visit Our Web Site: https://www.marketsandmarkets.com

0 notes

myoliver123stuff · 4 years ago

Text

Spatial OMICS Market is estimated to reach at $1584.22 Mnby 2030

The global Spatial OMICS market size is expected to be worth around US$ 584.22 Mn by 2030, according to a new report by Trends Market Research.

The global Spatial OMICS market size was valued at US$ 305.81 Mn in 2020 and is anticipated to grow at a CAGR of 15.05% during forecast period 2021 to 2030.

Growth Factors

Startups and well-established players continued their product development and launched novel solutions, democratized their offerings beyond innovators, and engaged in mergers & acquisitions. The spatial OMICS field originated from hyperplexed imaging; however, key players have shifted toward the development of spatial transcriptomics solutions and products.

Rapid advances in the sequencing of tissues, genes, and single cells have resulted in the emergence of spatial genomic sequencing. Spatial OMICS techniques offer quantitative gene expression data and visualization of DNA and RNA mapping within tissue sections. The development of novel technologies for spatial OMICS is anticipated to create lucrative opportunities for the fields of translational research as well as diagnostics.

The spatial genomics technology segment is expected to expand at the fastest CAGR throughout the forecast period owing to a rise in the launch of novel platforms. The integration of high-throughput solutions in transcriptomics, genomics, and proteomics studies has enabled determining the link between disease occurrence and genome position.

Report Highlights

The spatial transcriptomics segment dominated the market with a share of 73.56% in 2020. Continuous advancements in sequencing technologies have accelerated the transcriptomic study of single cells. For the comprehensive study of multicellular organisms, efforts are being taken to design novel solutions for high-throughput genomic analysis while maintaining the spatial information of the sample/tissue under observation or subcellular localization of analyzed DNA/RNA.

Download Research Sample with Industry Insights @ https://www.trendsmarketresearch.com/report/sample/13641

The development of various in situ methods enhances the capabilities to explore spatial information in biological investigation. These methods have led to the convergence of function-oriented fields of biochemistry and molecular genetics with structure-focused fields such as histology and embryology, thereby enabling spatially resolved molecular investigation of biological processes.

The consumables segment accounted for the largest share of 63.01% in 2020 owing to the high utilization rate and launch of novel products. For instance, in March 2021, Bruker launched new consumables for the chemical cross-linking of proteins (XL-MS). The new PhoX cross-linker facilitates the purification of protein from XL-MS reaction complex mixtures. Moreover, the company plans to launch three cleavable cross-linkers for cleaving the cross-linkers generated in MS experiments.

The launch of new instruments is directly associated with the development of the consumables. Therefore, this drives the instruments as well as the consumables segment. In December 2020, NanoString announced the development of spatial molecular imager (SMI). It is a next-generation spatial OMICS platform designed for multiplexed protein and RNA analysis for single cells in FFPE tissue samples. The platform is expected to be launched by 2022.

The instrumental analysis segment dominated the market with a revenue share of 57.69% in 2020. The growth of the segment can be primarily attributed to substantial advancements being performed in instruments such as microscopy and mass spectrometry. Mass spectrometry is one of the most promising tools that is used for quantifying nucleic acid and proteins.

It has several advantages such as high resolution, high speed, and high-throughput operations for profiling of protein, which are later used for analyzing complex biological samples. This facilitates novel applications such as new drug development, biomarker discovery, and diagnostics.

The formalin fixation and paraffin-embedding (FFPE) segment held the largest share of 67.26% in 2020. FFPE is considered a standard sample type that is most used for the preservation of human tissue for clinical diagnosis, and hence it holds a major share in the global market. This technique is considered the best in researching tissue morphology for clinical histopathology and diagnostic purposes.

In addition, FFPE specimens are found in abundance in clinical tissue banks, which contributes to the segment growth. However, they are incompatible with single-cell level transcriptome sequencing owing to RNA degradation and RNA damage during storage and extraction. Hence, researchers are focusing on new approaches for increasing the application of FFPE in spatial transcriptomic studies.

The academic and translational research institutes segment dominated the market with a revenue share of 99.60% in 2020. An increase in the adoption of spatial OMICS to translate real-time tissue responses to an external agent increases the technology’s adoption in translational research. Translational studies in the field of genomics help researchers and healthcare practitioners analyze the behavior of human tissues and cells from different individuals in different environments.

This vital information may lead to the evolution of new and better ways to prevent diseases. For instance, single-cell transcriptomics is found to be useful for neuroscientists to understand cell types forming the brain. These methods help understand the spatial architecture of nervous tissues and evaluate the brain’s function. However, this further requires linking molecular cell types to physiological, morphological, and behavioral factors.

Direct Purchase this Market Research Report Now @ https://www.trendsmarketresearch.com/checkout/13641/Single

North America accounted for the largest share of 54.80% in 2020. This can be attributed to the increasing prevalence of cancer, the growing demand for personalized medicine, well-developed healthcare facilities, and the availability of novel diagnostic techniques. The growing morbidity and mortality rates due to cancer and other metabolic, autoimmune, and inflammatory disorders have led to an increase in the need for developing novel therapies, thereby driving the market in this region.

In addition, companies operating in North America are launching new initiatives and programs for discovering and increasing translational applications, which is further contributing to the market growth. For instance, in March 2021, NanoString Technologies, Inc. launched the Technology Access Program (TAP) through which the company will analyze tissue samples of patients using the Spatial Molecular Imager platform and GeoMx Digital Spatial Profiler. Hence, such initiatives help in expanding spatial biology applications in the region.

Key Players

10x Genomics

Dovetail Genomics

S2 Genomics, Inc.

NanoString Technologies, Inc.

Seven Bridges Genomics

PerkinElmer, Inc.

Bio-Techne

Danaher Corporation

IonPath, Inc.

Millennium Science Pty Ltd.

Akoya Biosciences, Inc.

Fluidigm Corporation

Diagenode Diagnostics

Biognosys AG

Rebus Biosystems

Ultivue, Inc.

Vizgen Corp.

BioSpyder Technologies

Bruker

Brooks Automation, Inc.

Market Segmentation

Technology Outlook

Spatial Transcriptomics

Sequencing-based Methods

Laser capture microdissection (LCM), by tissue type

FFPE tissue samples

Others

Transcriptome in-vivo analysis (TIVA)

In situ sequencing

Microtomy sequencing

Microscopy-based RNA Imaging Techniques, by methodsSingle Molecule RNA Fluorescence In-Situ Hybridization (smFISH) Padlock Probes/ Rolling Circle Amplification Branched DNA probes

Spatial GenomicsFISH Microscopy-based Live DNA Imaging Genome Perturbation Tools Massively-parallel Sequencing Biochemical Techniques Others

Spatial Proteomics Imaging TechniquesMicroscopy Multiplexed Ion Beam Imaging Mass Spectrometry Immunofluorescence Techniques Centrifugation Techniques Others

Product Outlook Instruments By ModeAutomated Semi-automated Manual By TypeSequencing Platforms IHC Microscopy Flow Cytometry Mass Spectrometry Others Consumables SoftwareBioinformatics tools Imaging tools Storage and management databases

Workflow OutlookSample Preparation Instrumental Analysis Data Analysis

Sample Type OutlookFFPE Fresh Frozen

End-use Outlook (Revenue, USD Million, 2017 - 2028)Academic & Translational Research Institutes Pharmaceutical and Biotechnology Companies

The Spatial OMICS market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

Get Up to 10 % Discount on single User @ https://www.trendsmarketresearch.com/report/discount/13641

The report provides size (in terms of volume and value) of Spatial OMICS market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Spatial OMICS market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Spatial OMICS market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Spatial OMICS market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

0 notes

daisyri-me · 4 years ago

Text

Bioinformatics Services Market Analysis Report by Top players – Life Technologies Co. & Celera Co.

The global Bioinformatics Services Market size is expected to value at USD 4.1 billion by 2024, due to increasing demand from healthcare sector to carry out various studies such as cell signaling, pathway metabolism, gene-receptor interactions, and target differentiation. Favorable government policies and initiatives coupled with increasing funding for genomics oriented research & development, rising demand for drug discovery as well as biomarker development processes are expected to stimulate the growth of bioinformatics services industry over the forecast period.

In addition, swift decline in cost of DNA sequencing is expected to play major role in future market growth of bioinformatics services market. Globally, the bioinformatics services industry is predicted to grow at higher CAGR in the forecast period, providing numerous opportunities for market players to invest for research and development in the market.

Get Exclusive Free Sample Copy Of This Report @ https://www.millioninsights.com/industry-reports/bioinformatics-services-market/request-sample

Massive investment for research & development by both government authorities & private bodies in the areas of metabolomics, proteomics, and transcriptomic is anticipated to foster market requirement of advanced IT solutions for large data storage and enhanced analysis .Studies involving proteomics and genomics require large arrays of structural information, which has to be stored and processed accordingly to extract information. The bioinformatics services helps to analyze and monitor large chunks of data with higher processing rate.

Incorporation of information and communication technology (ICT) infrastructure along with various operating entities or through relocation of data services with the help of cloud computing technology, which is maintained by a third parties, thus driving emerging demand, are predicted to fuel market growth over the next seven years. However, lack of skilled labor force and higher initial cost are some of the key challenges for sustained market growth. In addition, inability to adopt bioinformatics tools and lack of data integration are limiting market progress to a certain extent. Other factor restraining industry growth include high volume statistics management and industry consolidation, particularly applicable for end-user manufactures.

Various types of bioinformatics services include next generation sequencing (NGS), chemoinformatics, microarray data analysis, biological data curation, and scientific software testing services. Next generation sequencing (NGS) consists of targeted sequencing, transcriptome, whole genome, chip sequencing, de-novo assembly, and methyl sequencing analysis. These factors are expected to boost market demand for bioinformatics services in the near future.

The bioinformatics services market is broadly categorized into five major segments based on the application type such as genomics, transcriptomic, proteomics, metabolomics and drug discovery. The transcriptomic is considered as one of the fastest growing segment in the bioinformatics services industry with substantial revenue generation in the last few years.

Growing popularity of the transcriptomic segment is attributed to the rise in number of research projects in the field of transcriptomic and introduction of technological advancements for the study of RNA transcripts using bioinformatics based protocols. The genomics segment has also witnessed substantial growth owing to the growing adoption of real time disease management and shifting trend towards preventive medicine techniques.

The bioinformatics services market is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the implementation of latest technologies in healthcare sector, increase in the research & development activities in the region, and existence of well-established medical infrastructure. Asia-Pacific region is predicted to hold major market share in the bioinformatics services with massive growth in forecast period.

For More Information visit @ https://www.millioninsights.com/industry-reports/bioinformatics-services-market

Countries such as India, China and Japan are leading the Asia-Pacific market with substantial advancements in the healthcare infrastructure in the region, favorable government policies & initiatives, and significant investment by leading industry players considering potential growth opportunities in the region.

The key players in the bioinformatics services industry are Accelerys Inc., Qiagen Inc., GVK Biosciences Pvt., Ltd., Illumina Inc., Agilent technologies, Inc., Life Technologies Co., Celera Co., IBM Life sciences Co., Affymetrix, Inc., DNAnexus Co., and Geneva Bioinformatic S.A.

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email:[email protected]

#Bioinformatics Services Market Share

0 notes

sandlerresearch · 5 years ago

Text

RNA Analysis/ Transcriptomics Market by Product (Reagents, Instruments, Software), Technology (Microarrays, NGS, Sanger), Application (Clinical Diagnostics, Drug Discovery), End User (CROs, Hospitals), COVID-19 Impact - Global Forecast to 2025 published on

https://www.sandlerresearch.org/rna-analysis-transcriptomics-market-by-product-reagents-instruments-software-technology-microarrays-ngs-sanger-application-clinical-diagnostics-drug-discovery-end-user-cros-hospitals.html

The RNA analysis/transcriptomics market is expected to grow at a CAGR of 13.9% in the forecast period.

The RNA analysis/transcriptomics market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period. The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding for omics, and the increasing applications of RNA sequencing in the transcriptomics market. The increasing focus on biomarker discovery and toxicogenomics, along with the increasing interest in outsourcing services, is expected to offer significant growth opportunities for the players operating in the global RNA analysis/transcriptomics market. On the other hand, the requirement of high capital investments and data management issues are expected to restrain the growth of this market to a certain extent.

Based on product, the reagents/consumables segment holds the largest market share during the forecast period.

Based on product & service, the RNA analysis/Transcriptomics market is segmented into reagents/consumables, instruments, software, and services. The reagents/consumables segment accounted for the larger market share in 2019. The increasing demand for high-quality reagents and the repeated use of media and reagents in transcriptome studies. Additionally, the growing R&D activities in the pharmaceutical industry, growing government investments in the field of life science research, and the increasing research being undertaken with integrated omics studies are contributing to the market for consumables.

Based on technology, the sequencing technologies segment is expected to register the highest CAGR during the forecast period.

Based on technology, the RNA analysis/transcriptomics market is segmented into micro arrays, PCR, sequencing technologies (Sanger sequencing and NGS technologies), and RNAi (gene silencing). The sequencing technologies segment is expected to witness the highest growth during the forecast period. RNA sequencing allows direct access to sequences of mRNA and is an equitable technology, which makes it more suitable for target identification and drug discovery applications. RNA sequencing also helps to overcome several issues associated with microarrays, such as bias and variation due to hybridization and labeling efficiencies. Technological advancements in this segment are further set to drive market growth.

The drug discovery segment is expected to account for the largest share of the RNA analysis/transcriptomics market in 2019

The drug discovery segment accounted for the largest share of the market in 2019. This is attributed to the use of transcriptomics in drug discovery for target identification and validation, identification of efficacy and toxicity biomarkers from biological fluids, and investigation of drug action and toxicity mechanisms. The growing need to study a large number of genes to gain a better understanding of gene-to-drug interactions is further expected to drive the use of transcriptomic technologies in drug discovery applications.

CROs end user segment is expected to grow at the highest CAGR in the RNA analysis/transcriptomics market during the forecast period

Based on end user, the RNA analysis/transcriptomics market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & diagnostic centers, and contract research organizations. The contract research organizations (CROs) segment is expected to witness the highest growth during the forecast period. CROs provide affordable outlets for companies and academia to pursue new medicines and offer a cost-effective solution to developing drugs. They also support foundations, research institutions, and universities, in addition to government organizations, such as the NIH and EMA. These factors are driving the growth of this segment.

North America is expected to account for the largest share of the RNA analysis/transcriptomics market in 2019

In 2019, North America accounted for the largest share of the RNA analysis/transcriptomics market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the increasing development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, high life science research funding, high biopharmaceutical R&D expenditure, and the greater adoption of advanced technologies in North America. The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment.

Break of primary participants was as mentioned below:

By Company Type – Tier 1–35%, Tier 2–5%, and Tier 3–20%

By Designation – C-level–35%, Director-level–25%, Others–40%

By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%

Key players in the RNA analysis/transcriptomics market

The key players operating in the RNA analysis/transcriptomics market include Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Fluidigm Corporation (US), Eurofins Scientific (Germany), Sequentia Biotech SL (Spain), Acobiom (France), GenXPro GmbH (Germany), CD Genomics (US), Promega Corporation (US), Lexogen GmbH (Austria), Cenix BioScience GmbH (Germany), Takara Holdings, Inc. (Japan), bioMérieux SA (France), and LC Sciences LLC (US).

Research Coverage:

The report analyzes the RNA analysis/transcriptomics market and aims at estimating the market size and future growth potential of this market based on various segments such as product, technology, application, end user, and region. The report also includes a product portfolio matrix of various RNA analysis/transcriptomics products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

Market Penetration: Comprehensive information on product portfolios offered by the top players in the global RNA analysis/transcriptomics market. The report analyzes this market by product, technology, application, and end user

Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global RNA analysis/transcriptomics market

Market Development: Comprehensive information on the lucrative emerging markets by product, technology, application, and end user

Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global RNA analysis/transcriptomics market

Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global RNA analysis/transcriptomics market.

#Biotechnology

0 notes

jayu123-me · 5 years ago

Text

Transcriptomics Market Analysis,Trends,Forecast, 2016-2024

Global Transcriptomics Market: Brief Account

Transcriptomics incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomics market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomics solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.

Read report Overview-

https://www.transparencymarketresearch.com/transcriptomics-market.html

In terms of end use, type of product, and technology, the global transcriptomics market could be segmented to help participants make a careful analysis and find authentic growth opportunities.

The authors of the report have taken into account all the important aspects of the global transcriptomics market in order to provide a deep insight for buyers to ensure a lasting advancement in the business.

Global Transcriptomics Market: Trends and Opportunities

The international transcriptomics market is expected to gain impetus from the increasing amount of investments directed toward research and development activities in molecular genetics. Newer innovations such as those pertaining to next-generation sequencing (NGS) and RNA interference (RNAi) have birthed as a result of the technological advancements in the international transcriptomics market. With improved precision and accuracy, these cutting-edge technologies can be put to use with a view to help researchers analyze the transcriptional activity of a vast range of diverse organisms. This will in turn assist to furnish precise outcomes and manage colossal quantities of transcriptomics data with the help of improved data analysis practices.

Request PDF Brochure –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18464

High cost of service on account of the dearth of trained professionals and high input cost is projected to discourage end users from opting for transcriptomics. Howbeit, cheaper and novel technologies that keep cost in view are anticipated to set the tone for the global transcriptomics market. The analysts foresee a steady growth over the forecast years on the part of the global transcriptomics market as cardiac diseases coupled with pollution-related ailments spread their presence worldwide. Biotechnology research and drug innovation actively and extensively employ transcriptomics technologies.

Global Transcriptomics Market: Geographical Study

Prophesied to register a significant CAGR for the forecast years, Asia Pacific could rely on countries such as India, Japan, and China for its strong growth in the global transcriptomics market. The region is predicted to fuel the demand in the global transcriptomics market on the back of a widespread presence of a ballooning count of biotech as well as pharma firms. This could be underpinned by the tangible economic growth and government support witnessed therein.

REQUEST FOR COVID19 IMPACT ANALYSIS –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=18464

However, North America is envisioned to be crowned as the maximum shareholder in the global transcriptomics market. The dominance of this regional transcriptomics market could be due to the development and existence of top-tier pharmaceutical and biotechnology companies, especially in the U.S. The Middle East, Africa, Europe, and Latin America could be the other vital regions making a statement in the global transcriptomics market.

Global Transcriptomics Market: Competitive Scenario

Some of the top players functioning in the global transcriptomics market are Becton, GE Healthcare, Roche Diagnostics, Agilent Technologies, and Thermo Fisher Scientific. With most end users purchasing reagents in bulk, vendors in the global transcriptomics market could be benefited with a larger revenue in the transcriptomics consumables sector. Enzymes, reagents, and assays are frequently procured for the purpose of performing various tests in the transcriptomics consumables sector.

Explore Transparency Market Research’s award-winning coverage of the global (Energy) Industry

https://www.globenewswire.com/news-release/2019/09/26/1921110/0/en/Lead-acid-Battery-Scrap-Market-to-reach-US-19-Bn-by-2027-Market-to-Expand-as-Automotive-Manufacturers-Go-Green-Noted-TMR.html

0 notes

the-rachana · 3 years ago

Text

Transcriptomics Market to Grow with a Significant CAGR During the forecast period 2022-2030

The global transcriptomics market peaked at ~US$ 4.5 billion in 2021. The market is expected to witness a CAGR of ~ 13.50% from 2022 to 2030.

Significant development is observed in the usage of RNA sequencing, as it is becoming a vital approach for transcriptomics study. RNA sequencing truly has revolutionized transcriptome examination, permitting the quantification of gene expression levels and allele-specific expression in single research, as well as the affinity of new genes, splice isoforms, fusion transcripts, and extraordinary research into the world of non-coding RNA. The demand for RNA sequencing in the research field is growing because it uses a highly scientific study to obtain information at the genetic level, although it is highly sensitive to genes that produce output very smoothly when using this technology. RNA sequencing apart from its conventional usage is also deployed to overcome problems occurring due to microarray, such as an absence of command over the pool of transcripts analyzed, and differences occurring due to hybridization. It is possible to sequence and quantifies the transcriptional outputs of individual cells or thousands of samples using RNA sequencing (RNA-seq).

Get a Sample PDF of the Report - https://growthplusreports.com/inquiry/request-sample/transcriptomics-market/7733

Key Players Mentioned in the Transcriptomics Market:

· Bio-Rad Laboratories Inc.

· Thermo Fisher Scientific Inc.

· Agilent Technologies Inc.

· Illumina Inc.

· Qiagen N.V

· F. Hoffman La Roche Ltd.

· Eurofins Scientific SE

· Fluidigm Corporation

· Merck KgaA

· Acobiom

· CD Genomics

Segmentation by Products:

· Reagents

· Software

· Instruments

By Application:

· Drug Discovery

· Clinical Diagnostics

· Toxicogenomics

By Technology:

· Microarray

· Polymerase Chain Reaction

· Sequencing

Key Reasons to Purchase:

(1) To gain insightful analyses of the market and have a comprehensive understanding of the global market and its commercial landscape.

(2) Assess the production processes, major issues, and solutions to mitigate the development risk.

(3) To understand the most affecting driving and restraining forces in the Transcriptomics Market and its impact in the global market.

(4) Learn about the market strategies that are being adopted by leading respective organizations.

(5) To understand the outlook and prospects for the market.

Key Questions Answered in the Report Include:

(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.

(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?

(3) What are the major global Transcriptomics Market trends influencing the development of the market?

(4) What are the vital results of SWOT analysis of the major players operating in the Transcriptomics Market?

(5) What are the potential growth opportunities and threats faced by Major competitors in the market?

TOC of Global Transcriptomics Market

1 Scope of the Report

1.1 Market Ecosystem

1.2 Geographic Scope

1.3 Timeline Under Consideration

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Transcriptomics Market Executive Summary

2.1 World Market Overview

2.1.1 Global Market Size 2021-2031

2.1.2 Market Size CAGR by Region 2020 VS 2028

2.2 Transcriptomics Market Segment by Type

2.2.1 Type 1

2.2.2 Type 2

Browse the full report now: https://growthplusreports.com/report/transcriptomics-market/7733

About

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

0 notes

shristipbi · 6 years ago

Text

Cell Analysis Market | Size | Share | Industry Analysis By 2025

Advances And Applications Of Single Cell Analysis Market And Its Market Analysis

Single cell analysis is a technology helps to sequence the whole human genome at the single cell level. Single cell analysis includes the proteomics, genomics, metabolomics, epigenomics, and transcriptomics. Single cell analysis is carried to analyze and measure the cellular heterogeneity and to define the specific cell type or cell state in the given population. This technique has immense applications in the field of medicine by interpreting the life at fundamental level.

Increase in the prevalence of infectious diseases and chronic diseases such as cancer, immunological, and neurological disorders are anticipated to drive the global single cell sequencing review market. Rise in government funding for cell-based research, technological advancements in the single cell analysis instruments, rise in focus on personalized medicine, and rise in R&D activities in biotechnology and pharmaceutical sectors are expected to propel the global single cell genomics market. However, high cost of R&D, lack of skilled professionals, and ethical and legal issues in the interpretation may hamper the growth of global animal single cell analysis market.

Request Sample Report:https://precisionbusinessinsights.com/request-sample?product_id=22833

The global animal single cell analysis market is divided into following categories-

1. Product type

· Assay Kits

· Reagents

· Beads

· Micro Plates

· Others

2. Cell type

· Animal Cell

· Microbial Cell

· Plant cell

3. Technique

· Polymerase Chain Reaction (PCR)

· Next Generation Sequencing (NGS)

· Microscopy

· Flow Cytometry

· Spectrophotometry

· Others

4. Application

· Research Application

o Neurology Research

o Immunology Research

o Cancer Research

o Stem Cell Research

o Others

· Medical Application

o In Vitro Fertilization

o Noninvasive Prenatal Diagnosis

o Circulating Tumor Cell detection

5. End-users

· Hospitals and Diagnostic Laboratories

· IVF Centers and Cell Banks

· Academic and Research Laboratories

· Biopharmaceuticals and Biotechnology companies

And lastly, on the basis of the geographical regions, the global microbial single cell analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America single cell sequencing review market growth driven by increase in the R&D activities by the biotechnology and biopharmaceutical companies, rise in prevalence of chronic diseases such as cancer, and government initiatives such as single cell analysis program by National Institute of Health (U.S.) to overcome the challenges in this technique are expected to boost the market. Europe single cell genomics market has a lucrative growth, which is attributed to establishment of biopharmaceutical and biotechnology companies, rise in preference for personalized medicine, and increase in government funding for the cell-based research are expected to propel the market. However, a prominent growth observed in Asia Pacific microbial single cell analysis market due to escalation in medical tourism, large patient pool, and development in healthcare infrastructure are expected to drive the revenue of market.

Some of the key players in the global animal single cell genomics market include Merck KGaA (Germany), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), General Electric Company (U.K.), Bio-Rad Laboratories, Inc.(U.S.), Illumina, Inc. (U.S.), NuGEN Technologies Inc. (U.S.), 10x Genomics(U.S.). Some of the notable market developments in the global animal single cell analysis market include Becton, Dickinson and Company launching a single cell analysis platform BD Rhapsody for RNA expression analysis in 2016.

For More Information: https://precisionbusinessinsights.com/market-reports/single-cell-analysis-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: [email protected]

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

0 notes

lilywhiteflower-blog · 6 years ago

Text

Metabolomics Market - Current Outlook Of Industry & Forecast 2017-2025

Global Metabolomics Market: Snapshot

Metabolomics is the examination of small molecules, commonly known as metabolites. Such molecules are typically found inside cells, tissues, biofluids, or organisms. The interaction of such small molecules in a biological system are known as the metabolome. Metabolomics is done on a large scale.

Metabolomics is a powerful tool since metabolites and their concentrations directly reveal the underlying biochemical activity and condition of cells and tissues. The four conceptual approaches in metabolomics are metabolite profiling, target analysis, metabolomics, and metabolic fingerprinting.

The swiftly rising domain of metabolomics consists of strategies to uncover and quantify cellular metabolites leveraging latest analytical technologies along with statistical and multi-variant methods for extracting information and analyzing data.

The past 20 years saw impressive strides being made in the sequencing of numerous organisms. Massive amounts were also earmarked for building analytical approaches to study various cell products, such as those from gene expression, metabolites, and proteins. All such approaches, namely genomics, proteomics, transcriptomics, and metabolomics are crucial tools used to comprehend an organism’s and its reaction to genetic perturbation or environmental stimuli.

Metabolomics finds application in determining gene function, phenotyping of genetically modified plants and substantial equivalence testing, and understanding responses to abiotic and biotic stress. Metabolomics thus bridges the gap between phenotype and genotype, offering an understanding of how cells function, along with uncovering of novel or striking changes in particular metabolites. Analysis and mining of metabolomic data sets and their metadata has the potential to bring about new hypotheses and targets for biotechnology.

Metabolomics, however, is hamstrung on account of the wide array of chemical structures with no one technology present to study the complete metabolome. Hence, quite a few additional approaches have to be set for extracting, detecting, quantifying, and identifying the metabolites.

Request Sample Copy of the Report @

https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2063

Global Metabolomics Market: Overview

Metabolomics refer to the study of the metabolites that exist within an organism, tissue, or a cell. Processes such as interpretation, quantification, identification, and profiling are used for the understanding the entire set of metabolites in a given biological system. This fairly new field of science is gaining attention as it is provides a comprehensive outlook of the phenotype of organelles, tissues, cells, organs, and whole organisms as compared to RNA, DNA, or protein profile.

Global Metabolomics Market: Key Trends

Soaring investments in both private players and government bodies in research and development of efficient metabolomics. The global market is expected to be supported by the continuous technological advancements and the untapped potential of the emerging economies. Furthermore, the increasing expenditure on biotechnology research and development has also had a positive impact on the global market. Metabolomics have gained a prime spot in the field of medicine has they offer a deeper understanding of way diseases function. Furthermore, they provide accurate protein profiling. Today, bioinformatics-based metabolomics are being used in clinical research, pharmaceutical research, plant and animal phenotyping, nutrition research, food and beverage analysis, environmental science, and biofuel development.

Request TOC of the Report @

https://www.tmrresearch.com/sample/sample?flag=T&rep_id=2063

Global Metabolomics Market: Market Potential

Several market players are focusing on mergers and acquisition to acquire newer talent and expertise to their existing pool. Companies are also expected to resort to collaborating with smaller and local players to expand their geographic reach. In line with the same sentiment, Metabolon Inc. recently announced that will take part in a larger studies that using metabolomics to understand large population health issues. For the same purpose, the Company has joined hands with Alex Forrest-Hay, Vice President of Population Health. This move is aimed at the maximizing the value of combining metabolomics and genomics to determine the risk of targets and facts for developing preventive healthcare.

Thus, the ongoing collaborations and joint ventures are being targeted toward studying health conditions of large groups of people over a period of time to gain a valuable insight of the nature of diseases, disorders, and various evolving conditions. The field of metabolomics is expected find ample of scope for growth in this area has it is known to deliver precision-driven results.

Global Metabolomics Market: Regional Outlook

From the geographic point of view, the global metabolomics market is segmented into North America, the Middle East and Africa, Europe, Asia Pacific, and Latin America. The report suggests that North America is slated to dominate the global market in the coming years due to a robust research infrastructure and a growing demand for personalized medicines. The high acceptance of technologically advanced products is also anticipated to support the regional market’s rise as a leading geographic segment in the global during the forecast period.

The study mentions that Asia Pacific is also expected to crucial to the progress of the global metabolomics market. A huge pool of aging population, which brings with a range of illnesses has given the pharmaceutical companies in the region an edge over others. Additionally, the growing demand for improved healthcare and pharmaceutical products, investments in life sciences, and demand for access to healthcare facilities have collectively opened up new avenues for growth for the Asia Pacific metabolomics market.

Key Players Mentioned in this Report are:

The chief operating players directing the progress and pace of the global metabolomics market are LECO Corporation, Shimadzu Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Biocrates Life Sciences AG, Bruker Corporation, Thermo Fisher Scientific, Inc., Danaher Corporation, Waters Corporation, Human Metabolome Technologies Inc., and Metabolon Inc.

Read Comprehensive Overview of Report @

https://www.tmrresearch.com/metabolomics-market

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Email: [email protected]

#Global Metabolomics Market

0 notes

market-researchm · 6 years ago

Text

Bioinformatics Services Industry Overview By Applications | Investment and Profit | Forecast To 2024

Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/bioinformatics-services-market/request-sample

Browse Full Research Report @ https://www.millioninsights.com/industry-reports/bioinformatics-services-market

Market Segment:

Global Bioinformatics Services Outlook, by Type (Revenue, USD Million, 2013 - 2024) • NGS • Targeted Sequencing Analysis • Transcriptome Analysis • Whole Genome • Chip Seq Analysis • De novo Assembly • Methyl Seq Analysis • Cheminformatics • Sequence Analysis Platforms • Molecular Modeling • Docking • Clinical trial data management • Others • Microarray data analysis • Biological data curation • Scientific software testing • Other services

Global Bioinformatics Services Outlook, by Application (Revenue, USD Million, 2013 - 2024) • Genomics • Transcriptomics • Proteomics • Metabolomics • Drug Discovery • Others

Global Bioinformatics Services Outlook, by Sector (Revenue, USD Million, 2013 - 2024) • Medical • Animal • Agricultural • Academics

Bioinformatics Services Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • U.S. • Canada • Europe • Germany • UK • Asia Pacific • China • Japan • Latin America • Brazil • MEA • South Africa

For More Details Please Visit @ Million Insights

0 notes